RxDoctor Payments DataLook up a doctor →

Nicholas Martinez, MD

Gastroenterology · San Antonio, TXNPI 1174843726

Payments from drug & device makers

$1,620,214in general payments, 2019–2025

Across 645 payments — averaging $2511.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$1.1M
  • Teva Pharmaceuticals USA, Inc.$279K
  • E.r. Squibb & Sons, L.L.C.$86K
  • Gilead$72K
  • Phathom Pharmaceuticals, Inc.$49K
  • Amgen$12K
  • plus $9K from 34 others
$65,816in research payments, 2019–2025

Across 11 payments — averaging $5983.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$37K
  • Eli Lilly$29K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly33$1,112,974
Teva Pharmaceuticals USA, Inc.45$278,911
E.r. Squibb & Sons, L.L.C.9$85,778
Gilead11$72,161
Phathom Pharmaceuticals, Inc.60$48,821
Amgen8$12,172
AbbVie(2 entities)193$2,960
Johnson & Johnson(3 entities)109$1,451
Romark Laboratories, LC5$1,172
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC47$861
Takeda Pharmaceuticals U.S.A., Inc.34$710
Janssen Scientific Affairs, LLC4$493
Pfizer19$391
UCB, Inc.10$194
Olympus America Inc.1$149
Celltrion USA Inc.7$140
Sanofi5$99
Lilly USA, LLC4$71
Ironwood Pharmaceuticals, Inc5$69
Alfasigma USA, Inc.4$66
Nestle Healthcare Nutrition Inc.3$65
Bristol Myers Squibb4$64
Merck3$58
Aimmune Therapeutics, Inc.3$46
Regeneron Healthcare Solutions, Inc.2$41
Shionogi Inc2$39
Redhill Biopharma Inc.2$33
Shire North American Group Inc1$22
Biocon Biologics Inc1$21
Pharmacosmos Therapeutics Inc.1$21
Novo Nordisk1$21
Vivus LLC1$20
Daiichi Sankyo Inc.1$20
Madrigal Pharmaceuticals1$19
QOL Medical, LLC1$16
Organon1$13
Shield Therapeutics Inc1$13
Intercept Pharmaceuticals, Inc.1$13
Cumberland Pharmaceuticals, Inc.1$13
Braintree Laboratories, Inc.1$12

How this compares

$1,620,214 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024
$197,757
Medicare patients
275
Services billed
4,917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →